Rho-family driven activation of STATs has been shown to influence cancer cell proliferation, invasion and metastasis due to the stimulatory influence on pathways regulating cellular morphology, therefore, targeting these Rho-family-driven pathways should offer new therapeutic nodes of attack. This evidence concerns the gene RHO and cancer.